Thaҫi Diamant, PINTER, Andreas, SEBASTIAN, Michael, TERMEER, Chritsian, STICHERLING, Michael, GERDES, Sascha, SCHÄKEL, Knut, WEGNER, Sven, KRAMPE, Stefanie, BARTZ, Holger, RAUSCH, Christian, TAUT, Friedemann und EYERICH, Kilian, 2024. Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS). Freiburg: Universität.

Thaҫi D., Pinter, A., Sebastian, M., Termeer, C., Sticherling, M., Gerdes, S., Schäkel, K., Wegner, S., Krampe, S., Bartz, H., Rausch, C., Taut, F., Eyerich, K., 2024. Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS). Universität, Freiburg. https://doi.org/10.1093/bjd/ljad523

Thaҫi D., Pinter, A., Sebastian, M., Termeer, C., Sticherling, M., Gerdes, S., Schäkel, K., Wegner, S., Krampe, S., Bartz, H., Rausch, C., Taut, F., & Eyerich, K. (ca. 2024). Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS) [Cd]. Universität. https://doi.org/10.1093/bjd/ljad523

Thaҫi D, Pinter A, Sebastian M, Termeer C, Sticherling M, Gerdes S, Schäkel K, Wegner S, Krampe S, Bartz H, Rausch C, Taut F, Eyerich K (2024) Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS). Universität, Freiburg

Thaҫi Diamant/ Pinter, Andreas/ Sebastian, Michael/ Termeer, Chritsian/ Sticherling, Michael/ Gerdes, Sascha/ Schäkel, Knut/ Wegner, Sven/ Krampe, Stefanie/ Bartz, Holger/ Rausch, Christian/ Taut, Friedemann/ Eyerich, Kilian, Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS), Freiburg 2024.